Mass. General Laws c.94C § 19D-1/2

Patient education and dispensing of opioid antagonists by substance use disorder treatment facilities

This is an unofficial version of a Massachusetts General Law.

Updates

Added by St. 2024, c. 285, § 5, effective July 1, 2025.

Section 19D 1/2

(a)

For the purposes of this section, the following words shall, unless the context clearly requires otherwise, have the following meanings:

“Opioid antagonist”, as defined in section 19B.

“Substance use disorder treatment facility”, a facility licensed or approved by the department or the department of mental health to offer treatment for substance use disorder, including, but not limited to: (i) withdrawal management services; (ii) clinical stabilization services; (iii) transitional support services; (iv) residential support services; (v) community behavioral health center services; (vi) office-based opioid or addiction treatment services; or (vii) inpatient or outpatient substance use disorder services.

(b)

A substance use disorder treatment facility shall, upon discharge of a patient who has: (i) a history of using opioids; (ii) been diagnosed with opioid use disorder; or (iii) experienced an opioid-related overdose, educate the patient on the use of opioid antagonists and dispense not less than 2 doses of an opioid antagonist to the patient or a legal guardian.

(c)

The commissioner may promulgate rules and regulations necessary to implement this section.

Last updated:	December 23, 2024